Induction of ovulation with human postmenopausal gonadotropin. 3. Effect of varying dosage schedules on estrogen and pregnanediol excretion levels.
D000328:Adult; D006063:Chorionic Gonadotropin / Q000627:therapeutic use*; D003338:Corpus Luteum / Q000187:drug effects; D004967:Estrogens / Q000652:urine*; D005260:Female; D005640:Follicle Stimulating Hormone / Q000652:urine; D006065:Gonadotropins, Pituitary / Q000627:therapeutic use*; D006801:Humans; D007247:Infertility, Female / Q000188:drug therapy*; D007986:Luteinizing Hormone / Q000652:urine; D010060:Ovulation / Q000187:drug effects*; D011247:Pregnancy; D011276:Pregnanediol / Q000652:urine*
D006063:Chorionic Gonadotropin; D004967:Estrogens; D006065:Gonadotropins, Pituitary; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone; D011276:Pregnanediol